BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28649130)

  • 1. Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer.
    Li J; Yao QY; Xue JS; Wang LJ; Yuan Y; Tian XY; Su H; Wang SY; Chen WJ; Lu W; Zhou TY
    Acta Pharmacol Sin; 2017 Sep; 38(9):1282-1296. PubMed ID: 28649130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical PK/PD model for the combinatorial use of dexamethasone and sulpiride in the treatment of breast cancer.
    Yao QY; Li J; Chen R; Yao Y; Xue JS; Chen WJ; Lu W; Zhou TY
    Acta Pharmacol Sin; 2019 Dec; 40(12):1596-1602. PubMed ID: 31165782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adriamycin in combination with dexamethasone and octreotide lacks activity on the treatment of a 4T1 metastatic breast cancer model.
    Dalezis P; Trafalis DT; Geromichalos GD; Pissimissis N; Panagiotopoulou D; Galaktidou G; Papageorgiou E; Papageorgiou A; Lymperi M; Koutsilieris M
    Anticancer Drugs; 2017 Jun; 28(5):489-502. PubMed ID: 28272098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells.
    Wang S; Mou Z; Ma Y; Li J; Li J; Ji X; Wu K; Li L; Lu W; Zhou T
    Biochem Pharmacol; 2015 May; 95(2):98-109. PubMed ID: 25824241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4.
    McClements L; Annett S; Yakkundi A; O'Rourke M; Valentine A; Moustafa N; Alqudah A; Simões BM; Furlong F; Short A; McIntosh SA; McCarthy HO; Clarke RB; Robson T
    BMC Cancer; 2019 Apr; 19(1):351. PubMed ID: 30975104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone suppresses the growth of human non-small cell lung cancer via inducing estrogen sulfotransferase and inactivating estrogen.
    Wang LJ; Li J; Hao FR; Yuan Y; Li JY; Lu W; Zhou TY
    Acta Pharmacol Sin; 2016 Jun; 37(6):845-56. PubMed ID: 27133297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.
    Du Y; Shi A; Han B; Li S; Wu D; Jia H; Zheng C; Ren L; Fan Z
    Int J Oncol; 2014 Apr; 44(4):1385-93. PubMed ID: 24535190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural agent 4-vinylphenol targets metastasis and stemness features in breast cancer stem-like cells.
    Leung HW; Ko CH; Yue GG; Herr I; Lau CB
    Cancer Chemother Pharmacol; 2018 Aug; 82(2):185-197. PubMed ID: 29777274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of Cancer Stem-like Cells in Endocrine-Resistant Metastatic Breast Cancers Is Mediated by Stromal Microvesicles.
    Sansone P; Berishaj M; Rajasekhar VK; Ceccarelli C; Chang Q; Strillacci A; Savini C; Shapiro L; Bowman RL; Mastroleo C; De Carolis S; Daly L; Benito-Martin A; Perna F; Fabbri N; Healey JH; Spisni E; Cricca M; Lyden D; Bonafé M; Bromberg J
    Cancer Res; 2017 Apr; 77(8):1927-1941. PubMed ID: 28202520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the combination of RAD001 and docetaxel on breast cancer stem cells.
    Zhang X; Zhang S; Liu Y; Liu J; Ma Y; Zhu Y; Zhang J
    Eur J Cancer; 2012 Jul; 48(10):1581-92. PubMed ID: 22420943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor.
    Yao Y; Yao QY; Xue JS; Tian XY; An QM; Cui LX; Xu C; Su H; Yang L; Feng YY; Hao CY; Zhou TY
    Toxicol Appl Pharmacol; 2020 Aug; 401():115118. PubMed ID: 32619553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating breast cancer metastasis with cabazitaxel-loaded polymeric micelles.
    Zhong T; He B; Cao HQ; Tan T; Hu HY; Li YP; Zhang ZW
    Acta Pharmacol Sin; 2017 Jun; 38(6):924-930. PubMed ID: 28504249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRLX101, an investigational camptothecin-containing nanoparticle-drug conjugate, targets cancer stem cells and impedes resistance to antiangiogenic therapy in mouse models of breast cancer.
    Conley SJ; Baker TL; Burnett JP; Theisen RL; Lazarus D; Peters CG; Clouthier SG; Eliasof S; Wicha MS
    Breast Cancer Res Treat; 2015 Apr; 150(3):559-67. PubMed ID: 25833208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antitumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics.
    Wang H; Wang Y; Rayburn ER; Hill DL; Rinehart JJ; Zhang R
    Int J Oncol; 2007 Apr; 30(4):947-53. PubMed ID: 17332934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
    Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.
    Martin JL; Julovi SM; Lin MZ; de Silva HC; Boyle FM; Baxter RC
    Breast Cancer Res; 2017 Aug; 19(1):90. PubMed ID: 28778177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The indole alkaloid meleagrin, from the olive tree endophytic fungus Penicillium chrysogenum, as a novel lead for the control of c-Met-dependent breast cancer proliferation, migration and invasion.
    Mady MS; Mohyeldin MM; Ebrahim HY; Elsayed HE; Houssen WE; Haggag EG; Soliman RF; El Sayed KA
    Bioorg Med Chem; 2016 Jan; 24(2):113-22. PubMed ID: 26692349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-metastatic and pro-apoptotic effects elicited by combination photodynamic therapy with sonodynamic therapy on breast cancer both in vitro and in vivo.
    Wang P; Li C; Wang X; Xiong W; Feng X; Liu Q; Leung AW; Xu C
    Ultrason Sonochem; 2015 Mar; 23():116-27. PubMed ID: 25465095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.